Company profile: AltheaDx
1.1 - Company Overview
Company description
- Provider of molecular diagnostics and PCR-based services, including molecular biomarker discovery, assay development and validation, prospective/retrospective clinical trial testing, and gene expression and genotyping analysis for pre-clinical and clinical applications.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AltheaDx
Inflammatix
HQ: United States
Website
- Description: Provider of rapid immune system diagnostics and sepsis-focused research. Offers the TriVerity Acute Infection and Sepsis Test System—Myrna Instrument and TriVerity Test—to identify bacterial or viral infections and assess risk of severe illness; conducts therapy response prediction to refine sepsis subtypes and therapy selection; collaborates on drug and device development; and participates in the SUBSPACE Consortium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inflammatix company profile →
SensID
HQ: Germany
Website
- Description: Provider of reference materials for DNA diagnostic procedures, designed for R&D, validation, external control, accreditation preparation, round robin tests, and integration into diagnostic devices or kits. Offerings include cfDNA multiplex sets for liquid biopsy (AKT1, BRAF, ERBB2, KRAS, PIK3CA; EGFR for NSCLC) and FFPE reference standards (PIK3CA variants, MSI).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SensID company profile →
DermTech
HQ: United States
Website
- Description: Provider of non-invasive qPCR assays for skin samples collected via adhesive tape biopsy, analyzing multiple gene targets' RNA expression. Offerings include the DermTech Melanoma Test, a genomic test using adhesive tape-collected skin cells to detect markers associated with melanoma with a 99% negative predictive value, anticipated to be provided through a CLIA-certified laboratory in San Diego.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DermTech company profile →
Ascenda Bio
HQ: United States
Website
- Description: Provider of molecular PCR and DNA technology with high sensitivity and specificity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ascenda Bio company profile →
NantOmics
HQ: United States
Website
- Description: Provider of cloud-based molecular profiling tools for cancer care, including GPS Cancer, a comprehensive test integrating DNA sequencing, RNA sequencing, and proteomics to guide personalized treatment; an integrated panomic approach to detect tumor alterations; and machine vision AI software analyzing digital pathology to identify cancer subtypes and therapy resistance mechanisms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NantOmics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AltheaDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AltheaDx
2.2 - Growth funds investing in similar companies to AltheaDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AltheaDx
4.2 - Public trading comparable groups for AltheaDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →